Fortress Biotech
Fortress Biotech Shares Plummet as FDA Issues Complete Response Letter for Key Drug
Fortress Biotech (NASDAQ: FBIO) saw its stock plunge over 30% on October 1, 2025, following the U.S. Food and Drug Administration's (FDA) issuance of a Complete Response Letter (CRL) for its New Drug Application (NDA) for CUTX-101. This investigational treatment, developed for pediatric patients suffering from the